Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance

Go back to Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance

Integra LifeSciences (IART) Reports In-Line Q4 EPS, Offers FY Guidance

February 23, 2017 7:12 AM EST

Integra LifeSciences (NASDAQ: IART) reported Q4 EPS of $0.52, in-line with the analyst estimate of $0.52. Revenue for the quarter came in at $255.7 million versus the consensus estimate of $257.27 million.

GUIDANCE:

Integra LifeSciences sees FY2017 EPS of $1.88-$1.94, versus the consensus of $1.93.... More